News
5hon MSN
Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
Eli Lilly › Eli Lilly (NYSE: LLY) has been a terrific stock to own over the past 15 years; it has consistently outperformed ...
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
3h
Major retailer stops selling Mounjaro due to ‘nationwide shortages’ after customers panic buy stock
A MAJOR high street pharmacy has stopped selling Mounjaro amid a nationwide shortage of the popular fat jab. It comes just days after The Sun revealed the price of the ‘King Kong’ injection would ...
Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback